2017
DOI: 10.1007/s10597-017-0202-z
|View full text |Cite
|
Sign up to set email alerts
|

Reasons for Nonadherence to Psychiatric Medication and Cardiovascular Risk Factors Treatment Among Latino Bipolar Disorder Patients Living in Puerto Rico: A Qualitative Study

Abstract: Latinos with bipolar disorder (BD) have a high rate of nonadherence to psychiatric medication and treatment for other medical conditions such as cardiovascular disease (CVD) risk factors than non-Latinos with BD. The aim of this study is to identify patients' perspectives on the reasons for nonadherence to psychiatric medication and for CVD risk factors conditions in outpatients with BD. Three focus group sessions were held for a total of 22 adults ranging from 23 to 60 years old. Participants had BD, Type I/I… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(15 citation statements)
references
References 31 publications
1
14
0
Order By: Relevance
“…A majority of the studies (64%) were focused purely on BD. Of the 57 included studies, 33% (Arvilommi et al, 2014 ; Baldessarini et al, 2008 ; Bauer et al, 2013 ; Fleck, Corey, Strakowski, & Keck, 2005 ; Grover, Ghosh, Sarkar, Chakrabarti, & Avasthi, 2014 ; Hajda et al, 2015 ; Johnson et al, 2007 ; Jonsdottir et al, 2013 ; Jose, Bhaduri, & Mathew, 2003 ; Manwani et al, 2007 ; Nagesh, Kishore, & Raveesh, 2016 ; Pope & Scott, 2003 ; Ralat, Depp, & Bernal, 2018 ; Roe, Goldblatt, Baloush-Klienman, Swarbrick, & Davidson, 2009 ; Scott & Pope, 2002 ; Stentzel et al, 2018 ; Vieta et al, 2012 ) explicitly focused on exploring barriers to adherence. Table 2 describes the quality of the included studies.…”
Section: Resultsmentioning
confidence: 99%
“…A majority of the studies (64%) were focused purely on BD. Of the 57 included studies, 33% (Arvilommi et al, 2014 ; Baldessarini et al, 2008 ; Bauer et al, 2013 ; Fleck, Corey, Strakowski, & Keck, 2005 ; Grover, Ghosh, Sarkar, Chakrabarti, & Avasthi, 2014 ; Hajda et al, 2015 ; Johnson et al, 2007 ; Jonsdottir et al, 2013 ; Jose, Bhaduri, & Mathew, 2003 ; Manwani et al, 2007 ; Nagesh, Kishore, & Raveesh, 2016 ; Pope & Scott, 2003 ; Ralat, Depp, & Bernal, 2018 ; Roe, Goldblatt, Baloush-Klienman, Swarbrick, & Davidson, 2009 ; Scott & Pope, 2002 ; Stentzel et al, 2018 ; Vieta et al, 2012 ) explicitly focused on exploring barriers to adherence. Table 2 describes the quality of the included studies.…”
Section: Resultsmentioning
confidence: 99%
“…However, the comprehensive nature of the TDF should enable identification of all determinants relevant to behaviour change and any determinants that cannot be mapped to a TDF domain will still be extracted and mapped to new domains if appropriate 34. A further benefit of mapping determinants to the TDF is its linkage to behaviour change techniques 17. This approach was successfully applied by Allemann and colleagues to match adherence interventions to determinants of patient adherence 27.…”
Section: Methodsmentioning
confidence: 99%
“…The determinants of adherence may be different among patients taking lithium relative to other antipsychotics due to a variety of factors including regular blood test requirements of lithium, dietary restrictions and significant interactions with other medications. Thus, a systematic review without the date limits of the previous systematic review14 is warranted to better represent the mood stabilisers that were the mainstay of treatment in the earlier decades and not included in the previous review and to identify emerging research 17…”
Section: Introductionmentioning
confidence: 99%
“…The goal of this stage 1a was to draft the treatment protocol of a psychosocial intervention based on the input of the focus groups formed, in our earlier study, of BD patients at risk of CVD and thus create a manual [13]. We chose participants with BD because the literature reveals that Latinos with BD living in the continental United States are more likely to be nonadherent to psychiatric medication and to such medication as may be required for other medical conditions than are Euro-Americans [4,10].…”
Section: Stage Ia-development Of the Psychosocial Interventionmentioning
confidence: 99%
“…See Table 1. Figure 1 shows the barriers to and facilitators of adherence to BD and CVD medications as determined by an earlier study [13]. The topic and organization of the manual was discussed with several members of the team.…”
Section: Stage Ia-development Of the Psychosocial Interventionmentioning
confidence: 99%